InvestorsHub Logo
Followers 134
Posts 3737
Boards Moderated 0
Alias Born 01/28/2006

Re: Luckytouch post# 298247

Friday, 05/22/2020 2:34:25 PM

Friday, May 22, 2020 2:34:25 PM

Post# of 402819
You got it.

PR Brilacidins BDD successful controlled release study.

https://www.bddpharma.com/single-post/2020/02/13/Another-success-for-BDDs-patented-OralogiK%E2%84%A2-technology-with-positive-clinical-results-for-colon-targeting-formulation

Short summary from an IBD patient we site web site:

https://ibdnewstoday.com/2020/02/19/oral-brilacidin-well-tolerated-healthy-volunteers-delivery-localized-colon-trial/

There is no systemic absorption of Brilacidin from the GI tract. BDD technology can be adjusted to treat the SI for Crohn's disease which will be a separate study.

GLTA Farrell
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News